Indiana Medicaid To Cover GLP-1 Obesity Medications Through Federal BALANCE Model

Indiana Medicaid will expand access to select glucagon-like peptide-1 (GLP-1) medications for eligible beneficiaries living with obesity through the federal Better Approaches to Lifestyle and Nutrition for Comprehensive Health (BALANCE) Model. Under the model, participating pharmaceutical manufacturers will make select GLP-1 medications available to Indiana Medicaid for $245 per member per month. After the federal contribution, Indiana's share will be $85.16 per member per month.

Indiana Governor Mike Braun directed the Indiana Family and Social Services Administration (FSSA) on July 30, 2026, to participate in BALANCE. FSSA has not yet announced eligibility criteria or . . .